Cepheid CPHD recently launched its Xpert MRSA NxG assay in the commercial markets overseas, after the test won the CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices.
Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the ...
SUNNYVALE, Calif., Feb. 10, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that Warren Kocmond, formerly Executive Vice President and Chief Operating Officer, has been promoted to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback